SlideShare une entreprise Scribd logo
1  sur  15
Télécharger pour lire hors ligne
Irish Academic Patenting 1980 –
2012
June 2012
Tony Owens
Draft Paper
Study Objective and Research Questions
The objective of this piece of work was to analyse the commercial relevance
of inventive R&D work undertaken by mainly state-funded Irish R&D
performers. This was done by performing a moderately-detailed landscaping
study on the patent output of Irish patent owners (assignees) known to be
largely state-funded. The basis for this approach is the assumption that
commercially-valuable and original discoveries tend to be patented. As far as
is known, this study is the first ever quant/qual study of the commerciallyrelevant outputs of Ireland academic-led innovation system.

•
•
•
•
•
•

What IP is patented by Irish academic inventors?
Which institutions and inventors are prolific?
What subject‐matter areas are popular?
What trends are apparent?
What collaborations are apparent?
Which patent publications are highly cited?

shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
Study Design and Data Processing
Search

All patents assigned to Irish-registered assignees from Jan 1980 to May 2012

Aggregation

Fulltext downloads from PatSeer & Espacenet/USPTO (for analytics)

Selection

Organisation of patents into families based on common priority applications.
Manual selection of all patent assignees known to be Irish State‐controlled research
performers.

Cleanup

Merged assignee name variants or mis‐spellings.
Merged misspelt or variations of inventor names.
Stripped some patents with no apparent Irish academic connections.
Stripped and re‐downloaded some US patents with corrupt database entries.
Manually redefined family root members based on existence of an EP patent if present,
else a WO patent, else a GB patent, else an IE patent , else the earliest published family
member

Analytics

Fulltext word-mining using both user-defined and auto-generated taxonomies

Visualisation

Simple stats and correlations, heatmaps, 2D maps

Notes

The objective for some metrics is to identify unique invention records originating from
inventors employed by the Irish State (i.e. count a single representative record for each
patent family).
For other metrics it is more appropriate to include complete patent families, which has
been done
3

shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
Disclaimers
1.

Patent Landscaping is not a precise science
–

2.
3.
4.
5.
6.

Not all patent records included but representive sample of the inventive
output of the sector under study
•
may exclude some re‐assigned patents
•
excludes patents related to ‘invention leakage’ from the institution or
filed subsequently by leavers

Some ‘ultimate company’ names incorrect
Excludes data prior to 1980
Some missing data for C/Y 2003‐2004
Resident country status for academic inventors not always reliable
The views and opinions expressed in this paper are those of the author
and do not reflect the policy or position of affiliated companies, clients or
colleagues. They should not be utilised in policy development as they are
based on a limited data set and have not been subjected to peer review.

4
shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
Activity Levels – No. of Patent Families

5
shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
Priority Countries for Patent Families

6
shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
Inventor Productivity - Published Inventions

7
shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
Academic Assignee Timeline

8
shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
What has Irish academic R&D been inventing?

9
shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
Auto-Blood Pressure

Auto-Diode Structure

Auto-Optical Modulator

Auto-Enzyme Systems

0

Auto-Improved Cytokine Design

19952010

Auto-Thermal Interface

50 (2.6%)
NAT UNIV
IRELAND MAYN

Auto-Vascular Graft

12

20002010
0

Auto-Comprising Nanoparticles

64 (3.3%)
ROYAL COLL
SURGEONS IE

Auto-Death Receptor

0

Auto-Porous Microparticles

11

19952010

Auto-Holographic Recording

65 (3.3%)
DUB INST OF
TECH

Auto-Treatment of Infection

10

19892004
0.09

Auto-Fungal and Yeast Species

66 (3.4%)

ENTPR IRELAND

Auto-Metal Oxide

0

Auto-Semiconductor Materials

9

19761990

Auto-DNA Fragments

68 (3.5%)
INST FOR IND
RES &
STANDARDS

Auto-Lactobacillus Salivarius

8

19942010
0

Auto-Optical Communication System

78 (4%)
TEAGASC DAIRY
PRODUCTS RES
CT

Auto-Analysis System

7

20002011
0

Auto-Strain of Lactobacillus

84 (4.3%)

UNIV LIMERICK

Auto-Light Source

6

19972011
0

Auto-Treatment and Prophylaxis

194
(9.9%)
UNIV DUBLIN
CITY

Auto-Nucleotide Sequence

19892011
0.72

Auto-Data Processing

5

229
(11.7%)

Auto-Immune Response

UNIV COLL
DUBLIN (NUI
DUBLIN)

19892011
0.12

IE

4

272
(13.9%)

Auto-Nucleic Acid

NAT UNIV
IRELAND
GALWAY

CA

3

19882011
0.18

GB

396
(20.3%)
NAT UNIV
IRELAND CORK

FR

19792011
0.24

Key Inventor
(Top 5)

CN

2

Filing
Year
Range

JP

427
(21.9%)
TRINITY COLL
DUBLIN

No. of Filings in last 5
yrs vs Average of Top
20 Assignees

DE

1

Filing Trend
( Cumulative )

EP

Assignee

WO

#

Avera
ge
No.of
Total No.
Fwd
of
Cites
Records
per
Paten
ts

US

Coverage
(Includes families)

Auto-Producing Recombinant Biological
Products
Auto-Bifidobacterium in the Treatment of
Inflammatory Disease

Inventive Activity Summary (by Patent Assignee)

58

108

127

1

18

0

6

10

49

79

15

4

25

3

0

17

6

0

4

4

0

0

5

11

0

0

5

0

0

4

0

0

0

2

0

0

4

2

38

96

108

0

20

0

7

3

18

75

21

11

2

10

3

11

3

16

14

14

14

6

8

4

0

0

4

0

0

0

0

10

3

0

0

9

21

0

67

80

74

0

10

0

5

3

20

35

38

6

1

15

9

0

0

1

0

0

2

7

0

0

19

0

0

8

0

0

0

0

0

0

6

0

3

6

40

55

78

0

10

0

7

2

11

17

5

12

1

0

1

0

8

0

1

0

0

3

0

0

0

0

2

0

0

4

0

0

0

0

0

0

4

0

SIEMENS PLC(5)
YORKSHIRE WATER SERVICES
LTD(5)
AAMIC AB(4)
ROYAL COLL SURGEONS IE(4)
ENTPR IRELAND(3)

26

45

68

0

7

0

5

29

7

20

2

8

0

0

12

0

8

0

4

0

0

1

6

0

0

0

0

0

0

6

5

0

0

0

0

0

5

0

DUB INST OF TECH(3)
EUROP ECONOMIC
COMMUNITY(3)
COOK INC(2)
EIRECOMPOSITES TEORANTA(2)
LUCENT TECHNOLOGIES INC(2)

10

18

27

0

2

0

0

1

0

28

0

3

0

0

0

0

1

0

0

0

0

0

0

0

0

0

0

0

6

0

0

0

0

0

0

0

0

0

4

11

12

0

4

0

1

0

2

6

8

1

0

0

0

0

0

10

0

0

2

0

0

6

0

0

0

0

0

0

0

0

0

0

0

0

0

0

3

4

0

0

3

2

0

0

1

3

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

6

14

7

0

10

0

4

0

8

3

14

0

2

8

0

6

0

13

0

4

13

0

0

0

0

0

0

0

0

0

0

8

0

0

0

0

0

0

5

18

21

0

3

0

0

11

1

6

0

1

0

0

3

0

4

0

0

0

0

0

0

0

0

11

0

0

0

0

0

0

0

0

0

0

2

0

14

23

26

0

1

0

0

0

8

1

1

0

0

1

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

4

0

0

0

0

11

12

21

0

1

0

1

0

1

4

0

0

0

0

0

4

0

0

0

0

0

0

0

0

0

1

0

0

0

0

0

0

0

0

0

0

0

0

Co-Assignees

FOSTER TIMOTHY J(34)
MILLS KINGSTON(30)
SHVETS IGOR(30)
KELLEHER DERMOT(30)
WALSH JAMES(18)

TEXAS A & M UNIV SYS(12)
N/ A(11)
INHIBITEX INC(9)
NAT UNIV IRELAND CORK(7)
HITACHI EUROP LTD(4)

ROSS R PAUL(31)
O'MAHONY LIAM(27)
COLLINS JOHN KEVIN(26)
HILL COLIN(25)
MCCARTHY THOMAS
VALENTINE(23)

ENTPR IRELAND(41)
TEAGASC DAIRY PRODUCTS RES
CT(30)
BIORESEARCH IRELAND(9)
TRINITY COLL DUBLIN(7)
UNIV GENT(5)

BARRY THOMAS
GERARD(40)
SMITH TERENCE
JAMES(36)
MAHER MAJELLA(28)
SAMALI AFSHIN(22)
O'CONNOR LOUISE(21)
REGAN CIARAN M(24)
SMYTH BARRY JOSEPH(16)
DARCY RAPHAEL(13)
HENEGHAN CONOR(12)
FITZMAURICE DONALD(12)

ENTPR IRELAND(16)
BIORESEARCH IRELAND(9)
UNIV GRONINGEN(9)
DEGUSSA-HULS
AKTIENGASELLSCHAFT(8)
INSTITUCIO CATALANA DE
RECERCA(7)
AMERICAN BIOGENETIC
SCIENCES(14)
BIO MEDICAL RES LTD(5)
NAT DIGITAL RES CT(4)
RWTH AACHEN(4)
TRINITY COLL DUBLIN(4)

MACCRAITH BRIAN(23)
ELLINGBOE ALBERT
ROGERS(15)
MURPHY NOEL(14)
CLYNES MARTIN(14)
KILLARD ANTHONY
JOSEPH(13)
GRIMES RONAN(8)
WALSH EDMOND(8)
CONWAY THOMAS J(8)
MCGLOUGHLIN TIMOTHY
M(7)
WALSH MICHAEL(7)
ROSS R PAUL(54)
STANTON CATHERINE
GERARDINE(29)
HILL COLIN(27)
FITZGERALD GER(11)
ZELDER OSKAR(11)

NAT UNIV IRELAND CORK(30)
ENTPR IRELAND(5)
ALIMENTARY HEALTH LTD(4)
CORK INST OF TECHNOLOGY(2)
CALLAGHAN DONAL J O(1)

ANDERSON FRANCIS
JOSEPH(7)
MCLOUGHLIN THOMAS
PATRICK(5)
CARROLL FRANCIS
ALFRED(5)
HOARY MARTO JOSEPH(4)
COLLINS JOHN KEVIN(30)
O'SULLIVAN GERALD
CHRISTOPHER(27)
O'MAHONY LIAM(23)
SHANAHAN FERGUS(18)
BARRY THOMAS
GERARD(12)
MARTIN SUZANNE(18)
TOAL VINCENT(18)
NAYDENOVA IZABELA(14)
COYLE EUGENE(7)
ETACHERI VINODKUMAR(7)

No Co-Assignee Present

RAMTOOLA
ZEBUNNISSA(12)
KENNY DERMOT(11)
KELLY JOHN(7)
PABARI RITESH(7)
GREENWAY MATT(6)
FARRELL RONAN(6)
LOWRY JOHN(6)
MAHON BERNARD(6)
SHORTEN ROBERT(5)
Leith Douglas(4)

NAT UNIV IRELAND CORK(41)
NAT UNIV IRELAND GALWAY(16)
TEAGASC DAIRY PRODUCTS RES
CT(5)
UNIV DUBLIN CITY(3)
INNOGENETICS N.V.(1)
MINMET PLC DUBLIN(5)
RIO TINTO TECHNOLOGY DEV
LTD(5)
EUROP ECONOMIC
COMMUNITY(3)
UNIV LIMERICK(3)
NAT UNIV IRELAND MAYN(2)
UNIV DUBLIN CITY(4)
NAT UNIV IRELAND MAYN(1)

INST NAT SANTE RECH MED(4)
PASTEUR INSTITUT(4)
DUB INST OF TECH(2)
COLD SPRING HARBOR LAB(1)
ROYAL COLL SURGEONS IE(1)

10
shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
Top 20 Word‐mined Clusters
Each bubble = single patent family (invention)
Size of bubble  number of forward citations.
Intensity of bubble  recency of patent

Map of the most popular subject-matter of Irish state-funded inventions
(fulltext word-mining and classification taxonomy).
11
shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
Invention Portfolios of Irish State R&D Performers
Each bubble = single patent family (invention)
Size of bubble  number of forward citations.
Intensity of bubble  recency of patent

Map of Portfolio's of Patent Families assigned to Irish state-funded R&D performers.
shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609

12
Collaborations between Invention Portfolio Owners
Nodes represent invention assignees.
Lines between nodes  co-cited invention assignees.
No. of co-assigned inventions enumerated in red.

13
shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
Observations
1.
2.

3.
4.
5.
6.

Irish academic patenting is a relatively recent thing – negligible activity pre
Noughties (except TCD)
The inventions have low levels of forward citation (cites from more recently
filed patents) particularly after adjustment for self-citation. In marked
contrast to publication citation performance, only one ‘landmark’ patent was
identified (US6870657; Electrochromic device, to UCD).
Patenting was almost exclusively focused on four areas until post 2006; of
which only two (Photonics and Microbiology/Probiotic Foods) were
realistically capable of commercialisation by Irish indigenous firms.
A striking bias towards science and against engineering/technology is
apparent. Almost all prolific inventors are bioscientists.
Collaborations as evidenced by patent co‐assignment are primarily with
other academic research performers. There is little evidence of
significant/consistent engagement with commercial businesses.
There is evidence of changing policy in the recent arrival of
engineering/technology‐led patenting by the ‘IT’s’ – in particular DIT, WIT
and SOIT

14
shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
Tentative Conclusions
1.
2.
3.

4.

5.

The low level of forward citations (after adjustment for self-citation) raise
serious questions about the commercial relevance of previous academic
RDI activities.
The striking bias towards science and against technology and engineering
apparent in previous patenting severely limits scope for engagement with
industry and with SME’s in particular.
The leading funder of Irish academic R&D is SFI which funds four
thematic areas: nanotech, biotech, ICT and renewable technology.
Despite this, only one of these funding areas, biotech, has generated
significant patent output.
In the aggregate, patenting is a leading indicator of commercialisation.
The continued lack of significant and consistent co‐citation with industrial
collaborators strongly suggests that the history of failure of the largest
Irish academic RDI providers to deliver commercially‐relevant outputs
will continue.
The rise of patenting in certain of the ‘IT’s’ (WIT, DIT, SOIT) which tend to
be more engaged with Irish companies is a positive development.
15

shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609

Contenu connexe

Similaire à Irish academic patenting 1980 – 2012

IP from Research at Lancaster Univeristy. By Dr Gavin Smith.
IP from Research at Lancaster Univeristy. By Dr Gavin Smith.IP from Research at Lancaster Univeristy. By Dr Gavin Smith.
IP from Research at Lancaster Univeristy. By Dr Gavin Smith.InfoLab21, Lancaster University
 
HUB:BLE-2 07 Finding Your Market
HUB:BLE-2 07   Finding Your MarketHUB:BLE-2 07   Finding Your Market
HUB:BLE-2 07 Finding Your MarketSpace IDEAS Hub
 
etudiantPI-studentIP-eng.ppt
etudiantPI-studentIP-eng.pptetudiantPI-studentIP-eng.ppt
etudiantPI-studentIP-eng.pptssuser3458db
 
Patent investigation on LED phosphors and down-converters
Patent investigation on LED phosphors and down-convertersPatent investigation on LED phosphors and down-converters
Patent investigation on LED phosphors and down-convertersKnowmade
 
Your name is not good enough : an introduction to (and university perspectiv...
Your name is not good enough : an introduction to (and university perspectiv...Your name is not good enough : an introduction to (and university perspectiv...
Your name is not good enough : an introduction to (and university perspectiv...CIGScotland
 
Data Science Application in Business Portfolio & Risk Management
Data Science Application in Business Portfolio & Risk ManagementData Science Application in Business Portfolio & Risk Management
Data Science Application in Business Portfolio & Risk ManagementData Science Thailand
 
Introduction to Intellectual Property and Patent Searching
Introduction to Intellectual Property and Patent SearchingIntroduction to Intellectual Property and Patent Searching
Introduction to Intellectual Property and Patent SearchingJohn Meier
 
Tom Hockaday - Seminario 'Nuevos enfoques sobre políticas de innovación'
Tom Hockaday - Seminario 'Nuevos enfoques sobre políticas de innovación'Tom Hockaday - Seminario 'Nuevos enfoques sobre políticas de innovación'
Tom Hockaday - Seminario 'Nuevos enfoques sobre políticas de innovación'Fundación Ramón Areces
 
Introducing ORCID at Imperial College London
Introducing ORCID at Imperial College LondonIntroducing ORCID at Imperial College London
Introducing ORCID at Imperial College LondonTorsten Reimer
 
Non invasive Glucose Patent Landscape sample
Non invasive Glucose Patent Landscape sampleNon invasive Glucose Patent Landscape sample
Non invasive Glucose Patent Landscape sampleKnowmade
 
Patenting in Mobile Application and Technology
Patenting in Mobile Application and TechnologyPatenting in Mobile Application and Technology
Patenting in Mobile Application and TechnologyIndicThreads
 
Innovations in Academic-Industry Collaboration in Taiwan and Hong Kong
Innovations in Academic-Industry Collaboration in Taiwan and Hong KongInnovations in Academic-Industry Collaboration in Taiwan and Hong Kong
Innovations in Academic-Industry Collaboration in Taiwan and Hong KongLin Haiqiu
 
Robotic Employment Opportunities
Robotic Employment OpportunitiesRobotic Employment Opportunities
Robotic Employment OpportunitiesElliot Duff
 
Ip on a coffe break... be inventive... be creative... be free
Ip on a coffe break... be inventive... be creative... be freeIp on a coffe break... be inventive... be creative... be free
Ip on a coffe break... be inventive... be creative... be freeTanja Kalezic
 
Capsule endoscopy Patent Landscape 2014 Sample
Capsule endoscopy Patent Landscape 2014 SampleCapsule endoscopy Patent Landscape 2014 Sample
Capsule endoscopy Patent Landscape 2014 SampleKnowmade
 

Similaire à Irish academic patenting 1980 – 2012 (20)

IP from Research at Lancaster Univeristy. By Dr Gavin Smith.
IP from Research at Lancaster Univeristy. By Dr Gavin Smith.IP from Research at Lancaster Univeristy. By Dr Gavin Smith.
IP from Research at Lancaster Univeristy. By Dr Gavin Smith.
 
HUB:BLE-2 07 Finding Your Market
HUB:BLE-2 07   Finding Your MarketHUB:BLE-2 07   Finding Your Market
HUB:BLE-2 07 Finding Your Market
 
etudiantPI-studentIP-eng.ppt
etudiantPI-studentIP-eng.pptetudiantPI-studentIP-eng.ppt
etudiantPI-studentIP-eng.ppt
 
Patent investigation on LED phosphors and down-converters
Patent investigation on LED phosphors and down-convertersPatent investigation on LED phosphors and down-converters
Patent investigation on LED phosphors and down-converters
 
Your name is not good enough : an introduction to (and university perspectiv...
Your name is not good enough : an introduction to (and university perspectiv...Your name is not good enough : an introduction to (and university perspectiv...
Your name is not good enough : an introduction to (and university perspectiv...
 
Data Science Application in Business Portfolio & Risk Management
Data Science Application in Business Portfolio & Risk ManagementData Science Application in Business Portfolio & Risk Management
Data Science Application in Business Portfolio & Risk Management
 
Krakow slides 2013
Krakow slides 2013Krakow slides 2013
Krakow slides 2013
 
Introduction to Intellectual Property and Patent Searching
Introduction to Intellectual Property and Patent SearchingIntroduction to Intellectual Property and Patent Searching
Introduction to Intellectual Property and Patent Searching
 
Tom Hockaday - Seminario 'Nuevos enfoques sobre políticas de innovación'
Tom Hockaday - Seminario 'Nuevos enfoques sobre políticas de innovación'Tom Hockaday - Seminario 'Nuevos enfoques sobre políticas de innovación'
Tom Hockaday - Seminario 'Nuevos enfoques sobre políticas de innovación'
 
Introducing ORCID at Imperial College London
Introducing ORCID at Imperial College LondonIntroducing ORCID at Imperial College London
Introducing ORCID at Imperial College London
 
LES 9 september 2011
LES 9 september 2011LES 9 september 2011
LES 9 september 2011
 
Non invasive Glucose Patent Landscape sample
Non invasive Glucose Patent Landscape sampleNon invasive Glucose Patent Landscape sample
Non invasive Glucose Patent Landscape sample
 
Patenting in Mobile Application and Technology
Patenting in Mobile Application and TechnologyPatenting in Mobile Application and Technology
Patenting in Mobile Application and Technology
 
Innovations in Academic-Industry Collaboration in Taiwan and Hong Kong
Innovations in Academic-Industry Collaboration in Taiwan and Hong KongInnovations in Academic-Industry Collaboration in Taiwan and Hong Kong
Innovations in Academic-Industry Collaboration in Taiwan and Hong Kong
 
Robotic Employment Opportunities
Robotic Employment OpportunitiesRobotic Employment Opportunities
Robotic Employment Opportunities
 
UHI Research and the Knowledge Economy [Joe Irvine]
UHI Research and the Knowledge Economy [Joe Irvine]UHI Research and the Knowledge Economy [Joe Irvine]
UHI Research and the Knowledge Economy [Joe Irvine]
 
Platform Futures: Reflections from Practice
Platform Futures: Reflections from PracticePlatform Futures: Reflections from Practice
Platform Futures: Reflections from Practice
 
Ip on a coffe break... be inventive... be creative... be free
Ip on a coffe break... be inventive... be creative... be freeIp on a coffe break... be inventive... be creative... be free
Ip on a coffe break... be inventive... be creative... be free
 
Capsule endoscopy Patent Landscape 2014 Sample
Capsule endoscopy Patent Landscape 2014 SampleCapsule endoscopy Patent Landscape 2014 Sample
Capsule endoscopy Patent Landscape 2014 Sample
 
Going Global
Going GlobalGoing Global
Going Global
 

Dernier

Using IESVE for Loads, Sizing and Heat Pump Modeling to Achieve Decarbonization
Using IESVE for Loads, Sizing and Heat Pump Modeling to Achieve DecarbonizationUsing IESVE for Loads, Sizing and Heat Pump Modeling to Achieve Decarbonization
Using IESVE for Loads, Sizing and Heat Pump Modeling to Achieve DecarbonizationIES VE
 
Anypoint Code Builder , Google Pub sub connector and MuleSoft RPA
Anypoint Code Builder , Google Pub sub connector and MuleSoft RPAAnypoint Code Builder , Google Pub sub connector and MuleSoft RPA
Anypoint Code Builder , Google Pub sub connector and MuleSoft RPAshyamraj55
 
UiPath Studio Web workshop series - Day 8
UiPath Studio Web workshop series - Day 8UiPath Studio Web workshop series - Day 8
UiPath Studio Web workshop series - Day 8DianaGray10
 
Building AI-Driven Apps Using Semantic Kernel.pptx
Building AI-Driven Apps Using Semantic Kernel.pptxBuilding AI-Driven Apps Using Semantic Kernel.pptx
Building AI-Driven Apps Using Semantic Kernel.pptxUdaiappa Ramachandran
 
KubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCost
KubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCostKubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCost
KubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCostMatt Ray
 
AI You Can Trust - Ensuring Success with Data Integrity Webinar
AI You Can Trust - Ensuring Success with Data Integrity WebinarAI You Can Trust - Ensuring Success with Data Integrity Webinar
AI You Can Trust - Ensuring Success with Data Integrity WebinarPrecisely
 
Introduction to Matsuo Laboratory (ENG).pptx
Introduction to Matsuo Laboratory (ENG).pptxIntroduction to Matsuo Laboratory (ENG).pptx
Introduction to Matsuo Laboratory (ENG).pptxMatsuo Lab
 
COMPUTER 10 Lesson 8 - Building a Website
COMPUTER 10 Lesson 8 - Building a WebsiteCOMPUTER 10 Lesson 8 - Building a Website
COMPUTER 10 Lesson 8 - Building a Websitedgelyza
 
Videogame localization & technology_ how to enhance the power of translation.pdf
Videogame localization & technology_ how to enhance the power of translation.pdfVideogame localization & technology_ how to enhance the power of translation.pdf
Videogame localization & technology_ how to enhance the power of translation.pdfinfogdgmi
 
COMPUTER 10: Lesson 7 - File Storage and Online Collaboration
COMPUTER 10: Lesson 7 - File Storage and Online CollaborationCOMPUTER 10: Lesson 7 - File Storage and Online Collaboration
COMPUTER 10: Lesson 7 - File Storage and Online Collaborationbruanjhuli
 
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...Will Schroeder
 
How Accurate are Carbon Emissions Projections?
How Accurate are Carbon Emissions Projections?How Accurate are Carbon Emissions Projections?
How Accurate are Carbon Emissions Projections?IES VE
 
20230202 - Introduction to tis-py
20230202 - Introduction to tis-py20230202 - Introduction to tis-py
20230202 - Introduction to tis-pyJamie (Taka) Wang
 
Bird eye's view on Camunda open source ecosystem
Bird eye's view on Camunda open source ecosystemBird eye's view on Camunda open source ecosystem
Bird eye's view on Camunda open source ecosystemAsko Soukka
 
Secure your environment with UiPath and CyberArk technologies - Session 1
Secure your environment with UiPath and CyberArk technologies - Session 1Secure your environment with UiPath and CyberArk technologies - Session 1
Secure your environment with UiPath and CyberArk technologies - Session 1DianaGray10
 
Building Your Own AI Instance (TBLC AI )
Building Your Own AI Instance (TBLC AI )Building Your Own AI Instance (TBLC AI )
Building Your Own AI Instance (TBLC AI )Brian Pichman
 
The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...
The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...
The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...Aggregage
 
Meet the new FSP 3000 M-Flex800™
Meet the new FSP 3000 M-Flex800™Meet the new FSP 3000 M-Flex800™
Meet the new FSP 3000 M-Flex800™Adtran
 
UiPath Studio Web workshop series - Day 7
UiPath Studio Web workshop series - Day 7UiPath Studio Web workshop series - Day 7
UiPath Studio Web workshop series - Day 7DianaGray10
 

Dernier (20)

Using IESVE for Loads, Sizing and Heat Pump Modeling to Achieve Decarbonization
Using IESVE for Loads, Sizing and Heat Pump Modeling to Achieve DecarbonizationUsing IESVE for Loads, Sizing and Heat Pump Modeling to Achieve Decarbonization
Using IESVE for Loads, Sizing and Heat Pump Modeling to Achieve Decarbonization
 
Anypoint Code Builder , Google Pub sub connector and MuleSoft RPA
Anypoint Code Builder , Google Pub sub connector and MuleSoft RPAAnypoint Code Builder , Google Pub sub connector and MuleSoft RPA
Anypoint Code Builder , Google Pub sub connector and MuleSoft RPA
 
UiPath Studio Web workshop series - Day 8
UiPath Studio Web workshop series - Day 8UiPath Studio Web workshop series - Day 8
UiPath Studio Web workshop series - Day 8
 
Building AI-Driven Apps Using Semantic Kernel.pptx
Building AI-Driven Apps Using Semantic Kernel.pptxBuilding AI-Driven Apps Using Semantic Kernel.pptx
Building AI-Driven Apps Using Semantic Kernel.pptx
 
KubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCost
KubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCostKubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCost
KubeConEU24-Monitoring Kubernetes and Cloud Spend with OpenCost
 
AI You Can Trust - Ensuring Success with Data Integrity Webinar
AI You Can Trust - Ensuring Success with Data Integrity WebinarAI You Can Trust - Ensuring Success with Data Integrity Webinar
AI You Can Trust - Ensuring Success with Data Integrity Webinar
 
Introduction to Matsuo Laboratory (ENG).pptx
Introduction to Matsuo Laboratory (ENG).pptxIntroduction to Matsuo Laboratory (ENG).pptx
Introduction to Matsuo Laboratory (ENG).pptx
 
COMPUTER 10 Lesson 8 - Building a Website
COMPUTER 10 Lesson 8 - Building a WebsiteCOMPUTER 10 Lesson 8 - Building a Website
COMPUTER 10 Lesson 8 - Building a Website
 
20230104 - machine vision
20230104 - machine vision20230104 - machine vision
20230104 - machine vision
 
Videogame localization & technology_ how to enhance the power of translation.pdf
Videogame localization & technology_ how to enhance the power of translation.pdfVideogame localization & technology_ how to enhance the power of translation.pdf
Videogame localization & technology_ how to enhance the power of translation.pdf
 
COMPUTER 10: Lesson 7 - File Storage and Online Collaboration
COMPUTER 10: Lesson 7 - File Storage and Online CollaborationCOMPUTER 10: Lesson 7 - File Storage and Online Collaboration
COMPUTER 10: Lesson 7 - File Storage and Online Collaboration
 
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
Apres-Cyber - The Data Dilemma: Bridging Offensive Operations and Machine Lea...
 
How Accurate are Carbon Emissions Projections?
How Accurate are Carbon Emissions Projections?How Accurate are Carbon Emissions Projections?
How Accurate are Carbon Emissions Projections?
 
20230202 - Introduction to tis-py
20230202 - Introduction to tis-py20230202 - Introduction to tis-py
20230202 - Introduction to tis-py
 
Bird eye's view on Camunda open source ecosystem
Bird eye's view on Camunda open source ecosystemBird eye's view on Camunda open source ecosystem
Bird eye's view on Camunda open source ecosystem
 
Secure your environment with UiPath and CyberArk technologies - Session 1
Secure your environment with UiPath and CyberArk technologies - Session 1Secure your environment with UiPath and CyberArk technologies - Session 1
Secure your environment with UiPath and CyberArk technologies - Session 1
 
Building Your Own AI Instance (TBLC AI )
Building Your Own AI Instance (TBLC AI )Building Your Own AI Instance (TBLC AI )
Building Your Own AI Instance (TBLC AI )
 
The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...
The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...
The Data Metaverse: Unpacking the Roles, Use Cases, and Tech Trends in Data a...
 
Meet the new FSP 3000 M-Flex800™
Meet the new FSP 3000 M-Flex800™Meet the new FSP 3000 M-Flex800™
Meet the new FSP 3000 M-Flex800™
 
UiPath Studio Web workshop series - Day 7
UiPath Studio Web workshop series - Day 7UiPath Studio Web workshop series - Day 7
UiPath Studio Web workshop series - Day 7
 

Irish academic patenting 1980 – 2012

  • 1. Irish Academic Patenting 1980 – 2012 June 2012 Tony Owens Draft Paper
  • 2. Study Objective and Research Questions The objective of this piece of work was to analyse the commercial relevance of inventive R&D work undertaken by mainly state-funded Irish R&D performers. This was done by performing a moderately-detailed landscaping study on the patent output of Irish patent owners (assignees) known to be largely state-funded. The basis for this approach is the assumption that commercially-valuable and original discoveries tend to be patented. As far as is known, this study is the first ever quant/qual study of the commerciallyrelevant outputs of Ireland academic-led innovation system. • • • • • • What IP is patented by Irish academic inventors? Which institutions and inventors are prolific? What subject‐matter areas are popular? What trends are apparent? What collaborations are apparent? Which patent publications are highly cited? shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
  • 3. Study Design and Data Processing Search All patents assigned to Irish-registered assignees from Jan 1980 to May 2012 Aggregation Fulltext downloads from PatSeer & Espacenet/USPTO (for analytics) Selection Organisation of patents into families based on common priority applications. Manual selection of all patent assignees known to be Irish State‐controlled research performers. Cleanup Merged assignee name variants or mis‐spellings. Merged misspelt or variations of inventor names. Stripped some patents with no apparent Irish academic connections. Stripped and re‐downloaded some US patents with corrupt database entries. Manually redefined family root members based on existence of an EP patent if present, else a WO patent, else a GB patent, else an IE patent , else the earliest published family member Analytics Fulltext word-mining using both user-defined and auto-generated taxonomies Visualisation Simple stats and correlations, heatmaps, 2D maps Notes The objective for some metrics is to identify unique invention records originating from inventors employed by the Irish State (i.e. count a single representative record for each patent family). For other metrics it is more appropriate to include complete patent families, which has been done 3 shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
  • 4. Disclaimers 1. Patent Landscaping is not a precise science – 2. 3. 4. 5. 6. Not all patent records included but representive sample of the inventive output of the sector under study • may exclude some re‐assigned patents • excludes patents related to ‘invention leakage’ from the institution or filed subsequently by leavers Some ‘ultimate company’ names incorrect Excludes data prior to 1980 Some missing data for C/Y 2003‐2004 Resident country status for academic inventors not always reliable The views and opinions expressed in this paper are those of the author and do not reflect the policy or position of affiliated companies, clients or colleagues. They should not be utilised in policy development as they are based on a limited data set and have not been subjected to peer review. 4 shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
  • 5. Activity Levels – No. of Patent Families 5 shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
  • 6. Priority Countries for Patent Families 6 shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
  • 7. Inventor Productivity - Published Inventions 7 shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
  • 8. Academic Assignee Timeline 8 shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
  • 9. What has Irish academic R&D been inventing? 9 shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
  • 10. Auto-Blood Pressure Auto-Diode Structure Auto-Optical Modulator Auto-Enzyme Systems 0 Auto-Improved Cytokine Design 19952010 Auto-Thermal Interface 50 (2.6%) NAT UNIV IRELAND MAYN Auto-Vascular Graft 12 20002010 0 Auto-Comprising Nanoparticles 64 (3.3%) ROYAL COLL SURGEONS IE Auto-Death Receptor 0 Auto-Porous Microparticles 11 19952010 Auto-Holographic Recording 65 (3.3%) DUB INST OF TECH Auto-Treatment of Infection 10 19892004 0.09 Auto-Fungal and Yeast Species 66 (3.4%) ENTPR IRELAND Auto-Metal Oxide 0 Auto-Semiconductor Materials 9 19761990 Auto-DNA Fragments 68 (3.5%) INST FOR IND RES & STANDARDS Auto-Lactobacillus Salivarius 8 19942010 0 Auto-Optical Communication System 78 (4%) TEAGASC DAIRY PRODUCTS RES CT Auto-Analysis System 7 20002011 0 Auto-Strain of Lactobacillus 84 (4.3%) UNIV LIMERICK Auto-Light Source 6 19972011 0 Auto-Treatment and Prophylaxis 194 (9.9%) UNIV DUBLIN CITY Auto-Nucleotide Sequence 19892011 0.72 Auto-Data Processing 5 229 (11.7%) Auto-Immune Response UNIV COLL DUBLIN (NUI DUBLIN) 19892011 0.12 IE 4 272 (13.9%) Auto-Nucleic Acid NAT UNIV IRELAND GALWAY CA 3 19882011 0.18 GB 396 (20.3%) NAT UNIV IRELAND CORK FR 19792011 0.24 Key Inventor (Top 5) CN 2 Filing Year Range JP 427 (21.9%) TRINITY COLL DUBLIN No. of Filings in last 5 yrs vs Average of Top 20 Assignees DE 1 Filing Trend ( Cumulative ) EP Assignee WO # Avera ge No.of Total No. Fwd of Cites Records per Paten ts US Coverage (Includes families) Auto-Producing Recombinant Biological Products Auto-Bifidobacterium in the Treatment of Inflammatory Disease Inventive Activity Summary (by Patent Assignee) 58 108 127 1 18 0 6 10 49 79 15 4 25 3 0 17 6 0 4 4 0 0 5 11 0 0 5 0 0 4 0 0 0 2 0 0 4 2 38 96 108 0 20 0 7 3 18 75 21 11 2 10 3 11 3 16 14 14 14 6 8 4 0 0 4 0 0 0 0 10 3 0 0 9 21 0 67 80 74 0 10 0 5 3 20 35 38 6 1 15 9 0 0 1 0 0 2 7 0 0 19 0 0 8 0 0 0 0 0 0 6 0 3 6 40 55 78 0 10 0 7 2 11 17 5 12 1 0 1 0 8 0 1 0 0 3 0 0 0 0 2 0 0 4 0 0 0 0 0 0 4 0 SIEMENS PLC(5) YORKSHIRE WATER SERVICES LTD(5) AAMIC AB(4) ROYAL COLL SURGEONS IE(4) ENTPR IRELAND(3) 26 45 68 0 7 0 5 29 7 20 2 8 0 0 12 0 8 0 4 0 0 1 6 0 0 0 0 0 0 6 5 0 0 0 0 0 5 0 DUB INST OF TECH(3) EUROP ECONOMIC COMMUNITY(3) COOK INC(2) EIRECOMPOSITES TEORANTA(2) LUCENT TECHNOLOGIES INC(2) 10 18 27 0 2 0 0 1 0 28 0 3 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 6 0 0 0 0 0 0 0 0 0 4 11 12 0 4 0 1 0 2 6 8 1 0 0 0 0 0 10 0 0 2 0 0 6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 4 0 0 3 2 0 0 1 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 6 14 7 0 10 0 4 0 8 3 14 0 2 8 0 6 0 13 0 4 13 0 0 0 0 0 0 0 0 0 0 8 0 0 0 0 0 0 5 18 21 0 3 0 0 11 1 6 0 1 0 0 3 0 4 0 0 0 0 0 0 0 0 11 0 0 0 0 0 0 0 0 0 0 2 0 14 23 26 0 1 0 0 0 8 1 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 11 12 21 0 1 0 1 0 1 4 0 0 0 0 0 4 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 Co-Assignees FOSTER TIMOTHY J(34) MILLS KINGSTON(30) SHVETS IGOR(30) KELLEHER DERMOT(30) WALSH JAMES(18) TEXAS A & M UNIV SYS(12) N/ A(11) INHIBITEX INC(9) NAT UNIV IRELAND CORK(7) HITACHI EUROP LTD(4) ROSS R PAUL(31) O'MAHONY LIAM(27) COLLINS JOHN KEVIN(26) HILL COLIN(25) MCCARTHY THOMAS VALENTINE(23) ENTPR IRELAND(41) TEAGASC DAIRY PRODUCTS RES CT(30) BIORESEARCH IRELAND(9) TRINITY COLL DUBLIN(7) UNIV GENT(5) BARRY THOMAS GERARD(40) SMITH TERENCE JAMES(36) MAHER MAJELLA(28) SAMALI AFSHIN(22) O'CONNOR LOUISE(21) REGAN CIARAN M(24) SMYTH BARRY JOSEPH(16) DARCY RAPHAEL(13) HENEGHAN CONOR(12) FITZMAURICE DONALD(12) ENTPR IRELAND(16) BIORESEARCH IRELAND(9) UNIV GRONINGEN(9) DEGUSSA-HULS AKTIENGASELLSCHAFT(8) INSTITUCIO CATALANA DE RECERCA(7) AMERICAN BIOGENETIC SCIENCES(14) BIO MEDICAL RES LTD(5) NAT DIGITAL RES CT(4) RWTH AACHEN(4) TRINITY COLL DUBLIN(4) MACCRAITH BRIAN(23) ELLINGBOE ALBERT ROGERS(15) MURPHY NOEL(14) CLYNES MARTIN(14) KILLARD ANTHONY JOSEPH(13) GRIMES RONAN(8) WALSH EDMOND(8) CONWAY THOMAS J(8) MCGLOUGHLIN TIMOTHY M(7) WALSH MICHAEL(7) ROSS R PAUL(54) STANTON CATHERINE GERARDINE(29) HILL COLIN(27) FITZGERALD GER(11) ZELDER OSKAR(11) NAT UNIV IRELAND CORK(30) ENTPR IRELAND(5) ALIMENTARY HEALTH LTD(4) CORK INST OF TECHNOLOGY(2) CALLAGHAN DONAL J O(1) ANDERSON FRANCIS JOSEPH(7) MCLOUGHLIN THOMAS PATRICK(5) CARROLL FRANCIS ALFRED(5) HOARY MARTO JOSEPH(4) COLLINS JOHN KEVIN(30) O'SULLIVAN GERALD CHRISTOPHER(27) O'MAHONY LIAM(23) SHANAHAN FERGUS(18) BARRY THOMAS GERARD(12) MARTIN SUZANNE(18) TOAL VINCENT(18) NAYDENOVA IZABELA(14) COYLE EUGENE(7) ETACHERI VINODKUMAR(7) No Co-Assignee Present RAMTOOLA ZEBUNNISSA(12) KENNY DERMOT(11) KELLY JOHN(7) PABARI RITESH(7) GREENWAY MATT(6) FARRELL RONAN(6) LOWRY JOHN(6) MAHON BERNARD(6) SHORTEN ROBERT(5) Leith Douglas(4) NAT UNIV IRELAND CORK(41) NAT UNIV IRELAND GALWAY(16) TEAGASC DAIRY PRODUCTS RES CT(5) UNIV DUBLIN CITY(3) INNOGENETICS N.V.(1) MINMET PLC DUBLIN(5) RIO TINTO TECHNOLOGY DEV LTD(5) EUROP ECONOMIC COMMUNITY(3) UNIV LIMERICK(3) NAT UNIV IRELAND MAYN(2) UNIV DUBLIN CITY(4) NAT UNIV IRELAND MAYN(1) INST NAT SANTE RECH MED(4) PASTEUR INSTITUT(4) DUB INST OF TECH(2) COLD SPRING HARBOR LAB(1) ROYAL COLL SURGEONS IE(1) 10 shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
  • 11. Top 20 Word‐mined Clusters Each bubble = single patent family (invention) Size of bubble  number of forward citations. Intensity of bubble  recency of patent Map of the most popular subject-matter of Irish state-funded inventions (fulltext word-mining and classification taxonomy). 11 shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
  • 12. Invention Portfolios of Irish State R&D Performers Each bubble = single patent family (invention) Size of bubble  number of forward citations. Intensity of bubble  recency of patent Map of Portfolio's of Patent Families assigned to Irish state-funded R&D performers. shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609 12
  • 13. Collaborations between Invention Portfolio Owners Nodes represent invention assignees. Lines between nodes  co-cited invention assignees. No. of co-assigned inventions enumerated in red. 13 shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
  • 14. Observations 1. 2. 3. 4. 5. 6. Irish academic patenting is a relatively recent thing – negligible activity pre Noughties (except TCD) The inventions have low levels of forward citation (cites from more recently filed patents) particularly after adjustment for self-citation. In marked contrast to publication citation performance, only one ‘landmark’ patent was identified (US6870657; Electrochromic device, to UCD). Patenting was almost exclusively focused on four areas until post 2006; of which only two (Photonics and Microbiology/Probiotic Foods) were realistically capable of commercialisation by Irish indigenous firms. A striking bias towards science and against engineering/technology is apparent. Almost all prolific inventors are bioscientists. Collaborations as evidenced by patent co‐assignment are primarily with other academic research performers. There is little evidence of significant/consistent engagement with commercial businesses. There is evidence of changing policy in the recent arrival of engineering/technology‐led patenting by the ‘IT’s’ – in particular DIT, WIT and SOIT 14 shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609
  • 15. Tentative Conclusions 1. 2. 3. 4. 5. The low level of forward citations (after adjustment for self-citation) raise serious questions about the commercial relevance of previous academic RDI activities. The striking bias towards science and against technology and engineering apparent in previous patenting severely limits scope for engagement with industry and with SME’s in particular. The leading funder of Irish academic R&D is SFI which funds four thematic areas: nanotech, biotech, ICT and renewable technology. Despite this, only one of these funding areas, biotech, has generated significant patent output. In the aggregate, patenting is a leading indicator of commercialisation. The continued lack of significant and consistent co‐citation with industrial collaborators strongly suggests that the history of failure of the largest Irish academic RDI providers to deliver commercially‐relevant outputs will continue. The rise of patenting in certain of the ‘IT’s’ (WIT, DIT, SOIT) which tend to be more engaged with Irish companies is a positive development. 15 shibumi© | www. shibumi-consulting.net | info@shibumi-consulting.net | ++353 – (0)1 - 4429609